Regis Healthcare acquires Royal Freemasons' Victorian home care business

Regis Healthcare has announced the acquisition of Royal Freemasons' home care business, expanding its client base and annualised home care revenue.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Regis Healthcare Ltd (ASX: REG) share price is in focus today following news that the company will acquire Royal Freemasons Homes of Victoria's home care business, with the deal expected to lift its home care revenue by more than $10 million.

An older gentleman leans over his partner's shoulder as she looks at a tablet device while seated at a table.

Image source: Getty Images

What did Regis Healthcare report?

  • Regis to acquire Royal Freemasons Homes of Victoria's home care business, adding around 480 clients
  • Annualised home care revenue to rise to approximately $50 million
  • Acquisition funded from existing cash reserves
  • Transaction completion expected in the second quarter of FY27

What else do investors need to know?

The agreement to acquire Royal Freemasons' Victorian home care business expands Regis Healthcare's service footprint in Melbourne, building on its existing home care service hubs. The Royal Freemasons business delivers Commonwealth Home Support Programme and Support at Home services, further strengthening Regis' offerings in the community aged care sector.

This transaction is subject to regulatory approvals and other customary conditions. Regis will not be raising new equity or debt to fund the deal, as it will be fully funded using existing cash on hand.

What did Regis Healthcare management say?

Regis CEO Andrew Kinkade commented:

Royal Freemasons is a well-regarded home care provider that strengthens Regis' existing operations and expands our scale in Melbourne. We believe the enlarged home care business is well positioned to benefit from key industry tailwinds including an ageing population, increased Government funding, and a growing consumer preference to age in place. We are delighted to welcome Royal Freemason's clients and staff to the Regis family and look forward to continuing to deliver high-quality home care services and support.

What's next for Regis Healthcare?

With the addition of Royal Freemasons' home care clients and staff, Regis aims to further cement its position as a leading aged care provider in Australia. The company highlighted expected benefits from ongoing sector trends such as growing demand for in-home care and increased Government support.

Once the deal completes in the second quarter of FY27, Regis will be serving more than 10,000 clients nationwide, providing comprehensive care through both residential and home care channels. The company plans to leverage its expanded scale to enhance service delivery and pursue further growth opportunities.

Regis Healthcare share price snapshot

Over the past 12 months, Regis Healthcare shares have remained flat, slightly trailing the All Ordinaries Index (ASX: XAO), which has risen 2% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Healthcare Shares

Two researchers discussing results of a study with each other.
Healthcare Shares

CSL vs Telix shares: Which is the better buy?

One valuation immediately caught my attention, while the other requires considerably more confidence in future growth.

Read more »

A healthcare worker wearing a white coat holds his fingers to his mouth looking worried as healthcare stocks like Cochlear crash today
Healthcare Shares

This ASX healthcare stock trades at its cheapest multiple in a decade

A quality business at a decade-low multiple. What gives?

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

CSL shares bounced in July after a brutal year: What's next?

Can CSL sustain July's rebound when it reports FY2026 results this month.

Read more »

Three businesswomen collaborate around a table.
Healthcare Shares

Clarity Pharmaceuticals reports clinical progress in June 2026 quarter

Clarity Pharmaceuticals reported $178.3 million in cash and strong clinical progress for the June 2026 quarter.

Read more »

A male doctor and a woman in scrubs in the foreground smile.
Healthcare Shares

Mesoblast FY26 earnings: Ryoncil revenue up, new trial milestones for ASX:MSB

Mesoblast reported a strong full year with US$115 million in Ryoncil revenue and advanced key clinical trials for future growth.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

CSL launches clinical trials for new plasma manufacturing process

CSL will launch clinical trials of its new Horizon 2 plasma process in 2027, seeking enhanced yields and regulatory approvals.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares before the end of July?

Here's what I expect from the beaten-down biotech stock next month.

Read more »

Concept image of a businessman riding a bull on an upwards arrow.
Broker Notes

Up 1,250% in a year, why 4DMedical shares can keep charging higher

A top analyst forecasts more outperformance from the surging shares.

Read more »